PT  - JOURNAL ARTICLE
AU  - Yusuke Katayama
AU  - Akikazu Fujita
AU  - Tohru Ohe
AU  - Ian Findlay
AU  - Yoshihisa Kurachi
TI  - Inhibitory Effects of Vesnarinone on Cloned Cardiac Delayed Rectifier K<sup>+</sup> Channels Expressed in a Mammalian Cell Line
DP  - 2000 Jul 01
TA  - Journal of Pharmacology and Experimental Therapeutics
PG  - 339--346
VI  - 294
IP  - 1
4099  - http://jpet.aspetjournals.org/content/294/1/339.short
4100  - http://jpet.aspetjournals.org/content/294/1/339.full
SO  - J Pharmacol Exp Ther2000 Jul 01; 294
AB  - Vesnarinone, a phosphodiesterase inhibitor, prolongs cardiac action potential duration by inhibiting the delayed rectifier K+current, IK. We examined the effect of this agent on human ether-a-go-go related gene (HERG) and KvLQT1/minK K+ channels heterologously expressed in human embryonic kidney 293T cells with the whole-cell patch-clamp technique. HERG channel current was inhibited by vesnarinone in a concentration-dependent manner, whereas KvLQT1/minK current was hardly affected by the drug. The inhibition of HERG current by vesnarinone became more prominent and faster as the membrane potential was more depolarized. The properties of inhibition could be described by a first order reaction between the drug and the channel that was apparently independent of HERG channel gating. Although the unbinding rate constant of the drug was constant, the apparent binding rate constant increased as the membrane was more depolarized and the drug concentration was raised. This model also could explain the fast recovery from the drug's effect at hyperpolarized potentials and its rate-dependent inhibition of HERG. Therefore, the effect of vesnarinone on the HERG-K+ current could be adequately described by a simple kinetic model of drug-channel interaction. The American Society for Pharmacology and Experimental Therapeutics